LIVE
Neuland Laboratories shares rose sharply on Thursday after the drugmaker reported a 975% year-on-year surge in Q1 FY27 profit to Rs 147.4 crore. Revenue more than doubled, while EBITDA jumped 448%, driven by strong commercial product sales and encouraging performance across its CMS and GDS businesses.
Neuland Laboratories shares jump over 6% after 975% YoY surge in Q1 profit
Impact Score
Market Sentiment
↑BullishPrimary Sectors
Neuland Laboratories shares rose sharply on Thursday after the drugmaker reported a 975% year-on-year surge in Q1 FY27 profit to Rs 147.4 crore. Revenue more than doubled, while EBITDA jumped 448%, driven by strong commercial product sales and encouraging performance across its CMS and GDS businesses.
Key Highlights
Neuland Laboratories shares rose sharply on Thursday after the drugmaker reported a 975% year-on-year surge in Q1 FY27 profit to Rs 147.4 crore.
Revenue more than doubled, while EBITDA jumped 448%, driven by strong commercial product sales and encouraging performance across its CMS and GDS businesses..
Source
Economic Times
Published
3h ago
Impact Score
75 / 100
Category
Corporate Earnings
Positive near-term momentum expected in Corporate Earnings as market digests this development.
What this means
No linked events found.